Glio Guide

A free Comprehensive Guide to Glioblastoma Wellness is now available www.glioguide.org
70 pages of in-depth information to help guide you in your decision making around this complex illness.

Use of chemotherapy can be associated with various side effects and complications. One notable risk that has emerged in recent studies is the increased likelihood of thromboembolic events, or blood clots, among patients undergoing chemotherapy for glioblastoma. This risk can be attributed to several factors, including the cancer itself, the effects of chemotherapy on blood coagulation pathways, and potential immobility during treatment.

The presence of blood clots can lead to serious complications, such as deep vein thrombosis (DVT) or pulmonary embolism (PE), both of which can significantly impact a patient's prognosis and quality of life. Healthcare providers are increasingly aware of this risk and are taking steps to monitor and manage it proactively. This includes assessing patients’ individual risk factors for clot formation and considering prophylactic measures, such as anticoagulants or encouraging mobility whenever possible. As research continues to evolve, understanding the relationship between glioblastoma chemotherapy and blood clot risk remains crucial for optimizing treatment strategies and improving patient outcomes.

Recent studies have indicated that sugar and refined carbohydrates can exacerbate the progression of glioblastoma, an aggressive form of brain cancer. Glioblastoma cells exhibit a heightened dependence on glucose for energy, a phenomenon known as the Warburg effect. This metabolic preference allows tumor cells to thrive in low-oxygen environments, enabling rapid growth and proliferation. High sugar and carbohydrate intake can lead to increased blood glucose levels, which may provide glioblastoma cells with the necessary fuel to expand and invade surrounding healthy brain tissue. Consequently, this can contribute to poorer patient outcomes and reduced effectiveness of traditional treatments.

Moreover, the consumption of sugar and carbohydrates can lead to systemic inflammation and insulin resistance, both of which are associated with cancer progression. Elevated insulin levels may stimulate cell growth and inhibit apoptosis (programmed cell death), creating a more favorable environment for glioblastoma cells. Additionally, diets high in sugars and refined carbs can lead to obesity and metabolic syndrome, both of which have been linked to an increased risk of various cancers, including glioblastoma. As a result, managing carbohydrate intake and reducing sugar consumption may serve as a potential adjunctive strategy in glioblastoma treatment, aiming to starve the tumor of its primary energy source and improve patient prognosis. A Keto diet is essential!

Welcome to Glioguide. Our team consists of retired healthcare professionals and researchers who recognize that allopathic medicine does not always have all the answers. We acknowledge the existence of legitimate complementary practices that can serve as alternatives, particularly when standard of care options have been exhausted. We firmly believe that patients should take charge of their own healthcare and have the power to influence their own outcomes. Please note that any information shared here should not be considered a substitute for professional medical advice or treatment.